Russia Allergy Market – Industry Trends and Forecast to 2030

Russia Allergy Market Analysis and Size

The increasing incidence of allergies can considerably impact the skin which is one of the largest targets for allergic and immunologic responses. As per the latest statistics, the incidence of allergies in the adult population is nearly to 30%, while in the pediatric population, it is nearly 50%. As per the official figures, the occurrence of allergy in Russia varies from 5% to 20.5%, while according to research conducted by the Institute of Immunology of the Federal Medical and Biological Agency, Russia, these figures varies between 17.5% and 30%.

Data Bridge Market Research analyses a growth rate in allergy market in the forecast period 2023-2030. The expected CAGR of allergy market is tend to be around 7.8% in the mentioned forecast period. The market was valued at USD 387.3 million in 2022, and it would grow upto USD 706.3 million by 2030. In addition to the market insights such as market value, growth rate, market segments, geographical coverage, market players, and market scenario, the market report curated by the Data Bridge Market Research team also includes in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.

Russia Allergy Market Scope and Segmentation

Market Definition

Allery is a condition in which immune system reacts abnormally to a foreign substance such as bee venom, pollen, pet dander, or a food that doesn't cause a reaction in most people. There are four different types of allergic reactions such as anaphylactic, ​​cytotoxic, immunocomplex, or cell-mediated, each one can manifest differently. Allergy symptoms that depend on the substance involved can affect the airways, sinuses and nasal passages, skin, and digestive system.

Russia Allergy Market Dynamics

Drivers

• Developed Growth on Product Launches

Key market players operating in the market are primarily concentrating on wide adoption of growth strategies such as product launch, regulatory approval, and R&D for the treatment of allergy, which is expected to boost the market growth during the forecast period. For instance, Eyevance Pharmaceuticals, a provider of ophthalmic products and therapies envisioned to address unmet medical needs in March 2020 announced the U.S. launch of Zerviate 0.24% for treating ocular itching associated with allergic conjunctivitis.

Opportunities

•  Increasing Demand of Prescription-Based Drugs

The prescription-based drugs rise the market growth resulting in approximately three-fifths of the Russia allergy treatment market, and is anticipated to maintain its leadership status during the forecast period, because of the increase in occurrence of allergy diseases and numerous initiatives taken by government & private organizations to spread awareness about allergic diseases.

• Increased Rate of Atopic Dermatitis

The global incidence of atopic dermatitis is increasing each year, mainly in the pediatric population: based on the latest estimates, 2%–10% of adults and 15%–30% of children are affected. In 45% of children suffering from atopic dermatitis, the condition arises at the age of 0–6 months, in 60% within the first year of life, and in 85% in the first 5 years of life. This boost the market growth.

 Restraints/Challenges

• Side Effects of Allergy

Drugs of this condition have numerous side effects such as rash, change in vision, eye pain, continued eye redness or irritation and other such problems. This hampers the market growth.

• Discontinuation of Multiple Drug Trials

The drug development for the disease has encountered major obstacles as many therapies have failed to demonstrate efficacy or were related with severe toxicity. Thus, this hampers the growth of the market.

This Russia allergy market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the Russia allergy market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Russia Allergy Market Scope

Russia allergy market is segmented on the basis of product, allergen type, disease areas, dosage form, route of administration, mode of purchase, end user, and distribution channel. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Product

• Antihistamines
• Corticosteroids
• Decongestants
• Monoclonal Antibody
• Mast Cell Stabilizers
• Immunotherapy
• Others

Allergan Type

• Airborne Allergens
• Food Allergens
• Insect Stings/ Bites
• Drug Allergens
• Metal/ Chemical Allergens
• Animal Saliva
• Others

Disease Areas

• Allergic Rhinitis
• Atopic Dermatitis
• Conjunctivitis
• Urticaria
• Asthma
• Anaphylaxis
• Venom Allergy
• Others

Dosage Form

• Liquid
• Solid
• Semi-Solid

Route of Administration

• Nasal
• Oral
• Parenteral
• Topical
• Others

Mode of Purchase

• Prescription
• Over the Counter

End User

• Hospitals
• Homecare
• Specialty Clinics
• Others

Distribution Channel

• Hospital Pharmacy
• Online Pharmacy
• Retail Pharmacy

Competitive Landscape and Russia Allergy Market Share Analysis

Russia allergy market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to allergy market.

Key players operating in the allergy market include:

• Novartis AG (Switzerland)
• Mylan N.V. (U.S.)
• Teva Pharmaceutical Industries Ltd. (Israel)
• Sanofi (France)
• Boehringer Ingelheim International GmbH. (Germany)
• AstraZeneca (U.K.)
• Johnson & Johnson Private Limited (U.S.)
• Bayer AG (Germany)
• Merck & Co., Inc. (U.S.)
• Dr. Reddy’s Laboratories Ltd. (India)
• Lupin (India)
• RusBioPharm (India)
• Santen Pharmaceutical Co., Ltd. (Japan)
• Viatris Inc. (U.K.)
• Sun Pharmaceutical Industries Ltd (India)

SKU-66025